BridgeBio Pharma, Inc. Capital Expenditures
BridgeBio Pharma, Inc. (BBIO) reported Capital Expenditures of $512.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $443.00K, a 25.42% decline year-over-year.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $69.00K.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $33.00K, a 29.79% decline year-over-year.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $470.00K, a 243.07% increase year-over-year.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.10M, a 17.58% increase from fiscal 2024.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $933.00K, a 28.56% decline from fiscal 2023.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.31M, a 72.91% decline from fiscal 2022.
- BridgeBio Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $4.82M, a 63.60% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $443.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $512.00K 10-Q · filed 2026-08-10 | $545.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.01M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $69.00K 10-Q · filed 2026-05-07 | $102.00K derived: sum of 2 quarters · filed 2026-05-07 | $572.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.17M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $503.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.10M derived: sum of 3 quarters · filed 2026-08-10 | $1.10M 10-K · filed 2026-02-24 |
| 2025-09-30 | $470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.06M derived: sum of 2 quarters · filed 2026-08-10 | $1.06M 10-Q · filed 2025-10-29 | $1.11M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $594.00K 10-Q · filed 2026-08-10 | $641.00K derived: sum of 3 quarters · filed 2026-08-10 | $778.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $47.00K derived: sum of 2 quarters · filed 2026-05-07 | $184.00K derived: sum of 3 quarters · filed 2026-05-07 | $238.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $184.00K derived: sum of 2 quarters · filed 2026-02-24 | $238.00K derived: sum of 3 quarters · filed 2026-02-24 | $933.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $191.00K derived: sum of 2 quarters · filed 2025-10-29 | $886.00K 10-Q · filed 2025-10-29 | $1.32M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $749.00K 10-Q · filed 2025-08-05 | $1.18M derived: sum of 3 quarters · filed 2026-02-24 | $1.61M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $695.00K 10-Q · filed 2025-04-29 | $1.13M derived: sum of 2 quarters · filed 2026-02-24 | $1.56M derived: sum of 3 quarters · filed 2026-02-24 | $1.99M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $866.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.29M derived: sum of 3 quarters · filed 2026-02-24 | $1.31M 10-K · filed 2026-02-24 |
| 2023-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $859.00K derived: sum of 2 quarters · filed 2024-11-12 | $871.00K 10-Q · filed 2024-11-12 | $1.67M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $440.00K 10-Q · filed 2024-08-01 | $1.24M derived: sum of 3 quarters · filed 2025-02-20 | $2.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $12.00K 10-Q · filed 2024-05-02 | $813.00K derived: sum of 2 quarters · filed 2025-02-20 | $1.57M derived: sum of 3 quarters · filed 2025-02-20 | $3.97M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $801.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.56M derived: sum of 2 quarters · filed 2025-02-20 | $3.96M derived: sum of 3 quarters · filed 2025-02-20 | $4.82M 10-K · filed 2025-02-20 |
| 2022-09-30 | $759.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.16M derived: sum of 2 quarters · filed 2023-11-02 | $4.02M 10-Q · filed 2023-11-02 | $6.56M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.26M 10-Q · filed 2023-08-03 | $5.80M derived: sum of 3 quarters · filed 2024-02-22 | $12.26M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $859.00K 10-Q · filed 2023-05-04 | $3.40M derived: sum of 2 quarters · filed 2024-02-22 | $9.86M derived: sum of 3 quarters · filed 2024-02-22 | $12.14M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $9.00M derived: sum of 2 quarters · filed 2024-02-22 | $11.29M derived: sum of 3 quarters · filed 2024-02-22 | $13.25M 10-K · filed 2024-02-22 |
| 2021-09-30 | $6.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $8.75M derived: sum of 2 quarters · filed 2022-11-03 | $10.71M 10-Q · filed 2022-11-03 | $12.86M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.25M 10-Q · filed 2022-08-04 | $6.39M derived: sum of 3 quarters · filed 2023-02-23 | $6.94M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.96M 10-Q · filed 2022-05-05 | $4.11M derived: sum of 2 quarters · filed 2023-02-23 | $4.66M derived: sum of 3 quarters · filed 2023-02-23 | $5.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.69M derived: sum of 2 quarters · filed 2023-02-23 | $3.04M derived: sum of 3 quarters · filed 2023-02-23 | $7.52M 10-K · filed 2023-02-23 |
| 2020-09-30 | $549.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $895.00K derived: sum of 2 quarters · filed 2021-11-04 | $5.37M 10-Q · filed 2021-11-04 | $7.12M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $346.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.82M 10-Q · filed 2021-08-05 | $6.57M derived: sum of 3 quarters · filed 2022-02-25 | $6.95M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $4.48M 10-Q · filed 2021-05-06 | $6.22M derived: sum of 2 quarters · filed 2022-02-25 | $6.61M derived: sum of 3 quarters · filed 2022-02-25 | $6.69M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $2.13M derived: sum of 2 quarters · filed 2022-02-25 | $2.21M derived: sum of 3 quarters · filed 2022-02-25 | $2.64M 10-K · filed 2022-02-25 |
| 2019-09-30 | $381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $464.00K derived: sum of 2 quarters · filed 2020-11-05 | $891.00K 10-Q · filed 2020-11-05 | $1.63M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $510.00K 10-Q · filed 2020-08-11 | $1.25M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2019-03-31 | $427.00K 10-Q · filed 2020-05-14 | $1.17M derived: sum of 2 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $741.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.18M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $1.44M 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $464.00K 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |